BCM
ARCT icon

Bayesian Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bayesian Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,400
Closed -$229K – 663
2024
Q2 		$229K Buy
+9,400
New +$285K 0.03% 573
2023
Q2 		– Sell
-9,499
Closed -$228K – 782
2023
Q1 		$228K Buy
+9,499
New +$170K 0.03% 580
2022
Q4 		– Sell
-11,399
Closed -$169K – 771
2022
Q3 		$169K Buy
+11,399
New +$191K 0.03% 539
2022
Q2 		– Sell
-8,300
Closed -$224K – 775
2022
Q1 		$224K Buy
+8,300
New +$212K 0.03% 619

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return